Evidence map›Paper›PMID 12034885›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue.

Joanne Fanelli Panus, Craig A Smith, Caroline A Ray, Terri Davis Smith, Dhavalkumar D Patel, David J Pickup

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. TNF Decoy Receptors Encoded by Poxviruses.Pathogens (Basel, Switzerland) · 2021
    Review
  6. Poxviral Strategies to Overcome Host Cell Apoptosis.Pathogens (Basel, Switzerland) · 2020
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. A survey of host range genes in poxvirus genomes.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2013
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joanne Fanelli PanusDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Craig A Smith
Caroline A Ray
Terri Davis Smith
Dhavalkumar D Patel
David J Pickup
Duke Medical Center · USDuke University Hospital · US

Funding

Viral Oncology Training GrantT32CA009111 · NCI · DUKE UNIVERSITY · PI LUFTIG, MICAH A. · 1985 to 2023
$8.9M
VIRAL INHIBITION OF HOST DEFENSESR21AI032982 · NIAID · DUKE UNIVERSITY · PI PICKUP, DAVID J · 2000 to 2000
$347k
VIRAL INHIBITION OF HOST DEFENSESR01AI032982 · NIAID · DUKE UNIVERSITY · PI PICKUP, DAVID J · 1992 to 1999
–
NCI NIH HHS T32 CA009111NCI NIH HHS T32 CA 09111NIAID NIH HHS AI 32982
6 · The paper itself

Abstract

Cowpox virus (Brighton Red strain) possesses one of the largest genomes in the Orthopoxvirus genus. Sequence analysis of a region of the genome that is type-specific for cowpox virus identified a gene, vCD30, encoding a soluble, secreted protein that is the fifth member of the tumor necrosis factor receptor family known to be encoded by cowpox virus. The vCD30 protein contains 110 aa, including a 21-residue signal peptide, a potential O-linked glycosylation site, and a 58-aa sequence sharing 51-59% identity with highly conserved extracellular segments of both mouse and human CD30. A vCD30Fc fusion protein binds CD153 (CD30 ligand) specifically, and it completely inhibits CD153/CD30 interactions. Although the functions of CD30 are not well understood, the existence of vCD30 suggests that the cellular receptor plays a significant role in normal immune responses. Viral inhibition of CD30 also lends support to the potential therapeutic value of targeting CD30 in human inflammatory and autoimmune diseases.

Indexed as

Amino Acid SequenceAnimalsCHO CellsCowpox virusCricetinaeEscherichia coliHumansKi-1 AntigenMolecular Sequence DataOsteosarcomaPlasmidsReceptors, Tumor Necrosis FactorRecombinant Fusion ProteinsRecombination, GeneticSequence AlignmentSequence Homology, Amino AcidKi-1 AntigenReceptors, Tumor Necrosis FactorRecombinant Fusion Proteins

Identifiers

PMID12034885
PMCPMC123070
OpenAlexW2125162265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.